Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette's syndrome: Comparison to obsessive compulsive disorder and normal controls

Biological Psychiatry

Volumn 39, Issue 9, 1996, Pages 776-783

  Chappell, Phillip ^a   Leckman, James ^a,c   Goodman, Wayne ^b,c   Bissette, Garth ^d   Pauls, David ^e   Anderson, George ^e   Riddle, Mark ^e   Scahill, Lawrence ^a   McDougle, Christopher ^b,c   Cohen, Donald ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale University   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e NONE

Author keywords

Cerebrospinal fluid; CRF; Norepinephrine; Obsessive compulsive disorder; Stress; Tourette syndrome

Indexed keywords

CORTICOTROPIN RELEASING FACTOR;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COMPULSION; CONTROLLED STUDY; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MALE; OBSESSION; PRIORITY JOURNAL; STRESS;

EID: 0029888904     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00221-9     Document Type: Article

References (57)

1. Altemus M, Pigott T, Kalogeras KT, Demitrack M, Dubbert B, Murphy DL, Gold PW (1992): Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder. Arch Gen Psychiatry 49:9-20.
2. Banki CM, Bissette G, Arato M, O'Connor L, Nemeroff CB (1987): CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am J Psychiatry 144:873-877.
3. Bornstein RA, Stefl ME, Hammond L (1990): A survey of Tourette syndrome patients and their families: the 1987 Ohio Tourette Survey. J Neuropsychiatry 2:275-281.
4. Brown MR, Fisher LA (1990): Regulation of the autonomic nervous system by corticotropin-releasing factor. In DeSouza EB, Nemeroff CB (eds), Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide. Boca Raton, FL, CRC Press, pp. 291-298.
5. Cador M, Duams S, Cole BJ, Mallet J, Koob GF, LeMoal M, Stinus L (1992): Behavioral sensitization induced by psycho-stimulants and stress: Search for a molecular basis and evidence for a CRF-dependent phenomenon. Ann NY Acad Sci 654:416-420.
6. Carney PA (1977): Recurrence of Gilles de la Tourette syndrome. Br Med J 1:884.
7. Chappell PB, Smith MA, Kilts CD, Bissette G, Ritchie J, Anderson C, Nemeroff CB (1986): Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci 6:2908-2914.
8. Chappell PB, Leckman JF, Pauls DP, Cohen DJ (1990): Biochemical and genetic studies of Tourette's syndrome: Implications for treatment and future research. In Deutsch SI, Weizman A, Weizman R (eds), Application of Basic Neuroscience to Child Psychiatry. New York, Plenum Press, pp. 241-260.
9. Chappell PB, Riddle M, Andersen G, Scahill L, Hardin M, Walker D, Cohen D, Leckman J (1994): Enhanced stress responsivity of Tourette syndrome patients undergoing lumbar puncture. Biol Psychiatry 36:35-43.
10. Chrousos GP, Gold PW (1992): The concepts of stress and stress system disorders. JAMA 267:1244-1252.
11. Coffey B, Frazier J, Chen S (1992): Comorbidity, Tourette syndrome, and anxiety disorders. In Chase TN, Friedhoff AJ, Cohen DJ (eds), Advances in Neurology, Vol. 58. New York, Raven Press, pp. 95-104.
12. Cohen DJ, Detlor JG, Lowe T (1980): Clonidine ameliorates Gilles de la Tourette syndrome. Arch Gen Psychiatry 37: 1350-1357.
13. Cole BJ, Cador M, Stinus L, Rivier C, Rivier J, Vale W, Le Moal M, Koob GF (1990): Critical role of the hypothalamic pituitary adrenal axis in amphetamine-induced sensitization of behavior. Life Sci 47:1715-1720.
14. DeSouza EB, Bissette G, Whitehouse PJ, Powers RE, Price DL, Vale WW, Nemeroff CB (1990): Abnormalities in corticotropin-releasing factor (CRF) in neurodegenerative diseases. In DeSouza EB, Nemeroff CB (eds), Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide. Boca Raton, FL, CRC Press, Inc., pp. 335-349.
15. Emoto H, Tanaka M, Koga C, Yokoo H, Tsuda A, Yoshida M (1993): Corticotropin-releasing factor activates the noradrenergic neuron system in the rat brain. Pharmacol Biochem Behav 45:419-422.
16. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleishmann RL, Hill CL, Heninger GR, Charney DS (1989): The Yale-Brown Obsessive Compulsive Scale (Y-BOCS): I. Development, use, and reliability. Arch Gen Psychiatry 46:1006-1011.
17. Hamilton M (1967): Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296.
18. Hamilton M (1959): The assessment of anxiety states by rating. Br J Psychol 32:50-55.
19. Kaye WH, Gwirtsman HE, George DT, Ebert MH, Jimerson DC, Tomai TP, Chrousos GP, Gold PW (1987): Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: Relation to state of nutrition, adrenal function, and intensity of depression. J Clin Endocrinol Metab 64:203-208.
20. Kling MA, Roy A, Doran AR, Calabrese JR, Rubinow DR, Whitfield HJ, May C, Post RM, Chrousos G, Gold PW (1991): Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: Potential clinical implications. J Clin Endocrinol Metab 72:260-271.
21. Koob GF, Heinrichs SC, Pich EM, Menzaghi F, Baldwin H, Miczek K, Britton KT (1993): The role of corticotropin-releasing factor in behavioral responses to stress. In Chadwick DJ, Marsh J, Ackrill K (eds), Corticotropin-Releasing Factor, Ciba Foundation Symposium 172. New York, John Wiley & Sons, pp. 277-295.
22. Leckman JF, Sholomskas D, Thompson WD, Belander A, Weissman MM (1982): Best estimate of lifetime psychiatric diagnoses: A methodological study. Arch Gen Psychiatry 39:879-883.
23. Leckman JF, Cohen DJ, Gertner JM, Ort S, Harcherik DF (1984): Growth hormone response to clonidine in children ages 4-17: Tourette's syndrome vs. children with short stature. Am Acad Child Adolesc Psychiatry 23:174-181.
24. Leckman JF, Ort S, Caruso KA, Anderson GM, Riddle MA, Cohen DJ (1986a): Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine. Arch Gen Psychiatry 43:1168-1176.
25. Leckman JF, Cohen DJ, Price RA, Riddle MA, Minderaa RB, Anderson GM, Pauls DL (1986b): The pathogenesis of Gilles de la Tourette syndrome: A review of data and hypothesis. In Shah AB, Shah NS, Donald AG (eds), Movement Disorders. New York, Plenum Press, pp. 257-272.
26. Leckman JF, Walkup JT, Riddle MA, Towbin KE, Cohen DJ (1987): Tic disorders. In Meltzer HY, Coyle JT, Kopin IJ, Bunney WE, Davis KL, Schuster CR, Shader RI, Simpson GM (eds), Psychopharmacology: The Third Generation of Progress. New York, Raven Press.
27. Leckman JF, Riddle MA, Berrettini WH, Anderson GM, Hardin M, Chappell P, Bissette G, Nemeroff CB, Goodman WK, Cohen DJ (1988): Elevated CSF dynorphin A[1-8] in Tourette's syndrome. Life Sci 43:2015-2023.
28. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ (1989): The Yale Global Tic Severity Scale (YGTSS): Initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28:566-573.
29. Leckman JF, Dolansky ES, Hardin MT, Clubb M, Walkup JT, Stevenson J, Pauls DL (1990): Perinatal factors in the expression of Tourette's syndrome: An exploratory study. J Am Acad Child Adolesc Psychiatry 29:220-226.
30. Leckman JF, Hardin MT, Riddle MR, Stevenson J, Ort S, Cohen DJ (1991): Clonidine treatment of Gilles de la Tourette syndrome. Arch Gen Psychiatry 1991; 48:1168-1176.
31. Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, Anderson GM, Riddle MA, McSwiggan-Hardin M, McDougle CJ, Barr LC, Cohen DJ: Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder: Comparison with Tourette's syndrome and healthy controls (1994). Arch Gen Psychiatry 51:782-793.
32. Leckman JF, Goodman WK, Anderson GM, Riddle MA, Chappell PB, McSwiggan-Hardin MT, McDougle CJ, Scahill LD, Ort SI, Pauls DL, Cohen DJ, Price LH (1995): CSF biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychopharmacology 12: 73-86.
33. Leonard HL, Lenane MC, Swedo SE, Rettew DC, Gershon ES, Rapoport JL (1992): Tics and Tourette's disorder: A 2- to 7-year follow-up of 54 obsessive-compulsive children. Am J Psychiatry 149:1244-1251.
34. Mueller N, Putz A, Klages U, Hofschuster E, Straube A, Ackenheil M (1994): Blunted growth hormone response to clonidine in Gilles de la Tourette syndrome. Psychoneuroendocrinology 19:335-341.
35. Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale W (1984): Elevated levels of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 266:1342-1343.
36. Owens MJ, Nemeroff CB (1993): The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: Laboratory and clinical studies. In Chadwick DJ, Marsh J, Ackrill K (eds), Corticotropin-Releasing Factor, Ciba Foundation Symposium 172. New York, John Wiley & Sons, pp. 296-316.
37. Pauls DL, Hurst CR (1987): Schedule for Tourette's Syndrome and Other Behavioral Disorders. New Haven, Yale University Child Study Center.
38. Pauls DP, Leckman JF, Cohen DJ (1993): Familial relationship between Giles de la Tourette's syndrome, attention deficit disorder, learning disabilities, speech disorders, and stuttering. J Am Acad Child Adolesc Psychiatry 32:1044-1050.
39. Peterson B, Riddle MA, Cohen DJ, Katz LD, Smith JC, Hardin MT, Leckman JF (1993): Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images. Neurology 43: 941-949.
40. Plotsky PM, Cunningham ET, Widmaier EP (1989): Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocrinol Rev 10:437-458.
41. Plotsky PM, Thrivikraman, Meaney MJ (1993): Central and feedback regulation of hypothalamic corticotropin-releasing factor secretion. In Chadwick DJ, Marsh J, Ackrill K (eds), Corticotropin-Releasing Factor, Ciba Foundation Symposium 172. New York, John Wiley & Sons, pp. 59-84.
42. Redmond DE (1987): Studies of the nucleus locus coeruleus in monkeys and hypotheses for neuropsychopharmacology. In Meltzer HY, Coyle JT, Kopin IJ, Bunney WE, Davis KL, Schuster CR, Shader RI, Simpson GM (eds), Psychopharmacology: The Third Generation of Progress. New York, Raven Press, pp. 967-975.
43. Rivier C, Smith M, Vale W (1990): Regulation of adrenocorticotropin hormone (ACTH) secretion by corticotropin-releasing factor (CRF). In DeSouza EB, Nemeroff CB (eds), Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide. Boca Raton, FL, CRC Press, Inc., pp. 175-189.
44. Robinson TE, Becker JB (1986): Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11:157-198.
45. Sawchenko PE, Swanson LW (1990): Organization of CRF immunoreactive cells and fibers in the rat brain: immunohistochemical studies. In DeSouza EB, Nemeroff CB (eds), Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide. Boca Raton, FL, CRC Press, pp. 29-51.
46. Shapiro AK, Shapiro ES, Young JG, Feinberg TE (1988): Gilles de la Tourette Syndrome. New York, Raven Press.
47. Siever LJ (1987): Role of noradrenergic mechanisms in the etiology of affective disorders. In Meltzer HY (ed), Psychopharmacology: The Third Generation of Progress. New York, Raven Press, pp. 493-504.
48. Sirinathsinghji DJ, Nikolarakis KE, Herz A (1990): Nigrostriatal dopamine mediates the stimulatory effects of corticotropin-releasing factor on methionine-enkephalin and dynorphin release from rat neostriatum. Brain Res 526:173-176.
49. Society of Actuaries (1959): Build and Blood Pressure Study. Chicago, Society of Actuaries, p. 16.
50. Stokes A, Bawden HN, Camfield PR, Backman JE, Dooley JM (1991): Peer problems in Tourette's disorder. Pediatrics 87:936-942.
51. Surwillo WW, Shafti M, Barrett CL: Gilles de la Tourette (1978): A 20-month study of the effects of stressful life events and haloperidol on symptom severity. J Nerv Ment Dis 166:812-816.
52. Sutton RE, Koof GF, Le Moal M, Rivier J, Vale W (1982): Corticotropin-releasing factor (CRF) produces behavioral activation in rats. Nature 297:331-333.
53. Swerdlow NR, Geyer GA, Vale WW, Koob GF (1986): Corticotropin releasing factor potentiates acoustic startle in rats: Blockade by chlordiazepoxide. Psychopharmacology 88:142-152.
54. Takahashi LK, Turner JG, Kalin NH (1992): Prenatal stress alters brain catcholaminergic activity and potentiates stress-induced behavior in adult rats. Brain Res 574:131-137.
55. Vale W, Spiess J, Rivier C, Rivier J (1981): Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213: 1394-1397.
56. Valentino RJ, Wehby RG (1988): Corticotropin-releasing factor: Evidence for a neurotransmitter role in the locus coeruleus during hemodynamic stress. Neuroendocrinology 48:674-677.
57. Walkup JT, Leckman JF, Price RA, Hardin MT, Ort S, Cohen DJ (1988): The relationship between Tourette's syndrome and obsessive compulsive disorder: A twin study. Psychopharmacol Bull 24:375-379.